Hansard
Consult the user guide
For assistance, please contact us
Consult the user guide
For assistance, please contact us
Add search criteria
Results: 1 - 1 of 1
View Tom Kmiec Profile
CPC (AB)
View Tom Kmiec Profile
2020-03-12 17:48 [p.2049]
Madam Speaker, the member for Fredericton mentioned that some members do not agree, so I thank her for recognizing that fact. I am pleased that she is here in the House and not her predecessor, whom I disagreed with often in this place.
Despite having disagreements, obviously we can agree that no patient should be left behind. The primary argument I have been making is that rare disease patients will be left behind in a national pharmacare system, because finding value for money and finding cost-effectiveness in the way the Hoskins report talks about requires picking which medications we will cover, and the current regulatory infrastructure and architecture that the federal government has will be simply enhanced.
Would the member agree that we should first fix the regulatory system we have before we try to impose an Ottawa-centric system on every single province across Canada?
Result: 1 - 1 of 1

Export As: XML CSV RSS

For more data options, please see Open Data